Artificial Intelligence (AI) In Drug Discovery Global Market Size ($4.71 Billion Revenue By 2028) Growing Rapidly with Recent Trends and Outlook

Overview and Scope
Artificial intelligence (AI) is a simulation of the human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

Sizing and Forecast
The artificial intelligence (ai) in drug discovery market size has grown exponentially in recent years. It will grow from $1.37 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 30.8%.  The  growth in the historic period can be attributed to growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence (ai) for cost efficient drug discovery and the increasing strict quality regulations for drug manufacturers.

The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $4.71 billion in 2028 at a compound annual growth rate (CAGR) of 27.4%.  The growth in the forecast period can be attributed to the government support, the increasing healthcare expenditure and rising adoption of cloud-based applications and services. Major trends in the forecast period include integration of multi-omics data, use of ai in target selection, use of ai in drug screening, introduction of ai innovation labs, increasing investments and partnerships and collaborations.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Segmentation & Regional Insights
The artificial intelligence (ai) in drug discovery market covered in this report is segmented –
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecules, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics
4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2023. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (ai) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Major Driver Impacting Market Growth
The growing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) in drug discovery market going forward. Personalized medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. AI can play a crucial role in the development of personalized medicines at all relevant phases of clinical development and implementation of new personalized health products by finding appropriate intervention targets and testing intervention targets for their utility. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Thus, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) in drug discovery market.

Key Industry Players
Major companies operating in the artificial intelligence (ai) in drug discovery market report are IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Atomwise Inc., Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., GSK Australia , CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI , Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Janssen Pharmaceutica, Teva Canada, Accord Healthcare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica , IQVIA, Quris, GE Healthcare, Avanade , Group42 Holding Ltd, Ilara Health, Adcock Ingram , Johnson & Johnson, Eurolab , Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech

The artificial intelligence (ai) in drug discovery market report table of contents includes:
1. Executive Summary

2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4. Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario

5. Global Artificial Intelligence (AI) In Drug Discovery Market Size and Growth

.....

32. Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking

33. Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market

35. Artificial Intelligence (AI) In Drug Discovery Market Future Outlook and Potential Analysis

36. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market

https://topprnews.com/organic-feed-market

https://topprnews.com/organic-pigments-market

https://goodprnews.com/rapeseed-oil-market

https://goodprnews.com/gluten-feed-market

https://goodprnews.com/manufactured-soil-market

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model